These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
43. Spontaneous evolution of human papillomavirus infection in the uterine cervix. Paraskevaidis E, Kalantaridou SN, Georgiou I, Koliopoulos G, Pappa L, Malamou-Mitsi V, Agnantis NJ, Kitchener HC, Lolis DE. Anticancer Res; 1999; 19(4C):3473-8. PubMed ID: 10629638 [Abstract] [Full Text] [Related]
44. Immunochemical analysis of human papillomavirus L1 capsid protein in liquid-based cytology samples from cervical lesions. Xiao W, Bian M, Ma L, Liu J, Chen Y, Yang B, Wu Q. Acta Cytol; 2010; 54(5):661-7. PubMed ID: 20968152 [Abstract] [Full Text] [Related]
45. Up-regulation of lipocalin 2 is associated with high-risk human papillomavirus and grade of cervical lesion at baseline but does not predict outcomes of infections or incident cervical intraepithelial neoplasia. Syrjänen S, Naud P, Sarian L, Derchain S, Roteli-Martins C, Tatti S, Branca M, Erzen M, Hammes LS, Costa S, Longatto-Filho A, Syrjänen K. Am J Clin Pathol; 2010 Jul; 134(1):50-9. PubMed ID: 20551266 [Abstract] [Full Text] [Related]
46. Relationship between cyclin G1 and human papilloma virus infection in cervical intraepithelial neoplasia and cervical carcinoma. Liang J, Bian ML, Chen QY, Liu X, Ou H, Li M, Liu J. Chin Med Sci J; 2006 Jun; 21(2):81-5. PubMed ID: 16845792 [Abstract] [Full Text] [Related]
48. Analysis of human papillomavirus type-16 variants in Italian women with cervical intraepithelial neoplasia and cervical cancer. Tornesello ML, Duraturo ML, Salatiello I, Buonaguro L, Losito S, Botti G, Stellato G, Greggi S, Piccoli R, Pilotti S, Stefanon B, De Palo G, Franceschi S, Buonaguro FM. J Med Virol; 2004 Sep; 74(1):117-26. PubMed ID: 15258977 [Abstract] [Full Text] [Related]
49. Single and multiple human papillomavirus infections in cervical abnormalities in Portuguese women. Pista A, Oliveira A, Verdasca N, Ribeiro F. Clin Microbiol Infect; 2011 Jun; 17(6):941-6. PubMed ID: 21040156 [Abstract] [Full Text] [Related]
50. A comparison of the clinical utility of p16(INK4a) immunolocalization with the presence of human papillomavirus by hybrid capture 2 for the detection of cervical dysplasia/neoplasia. Holladay EB, Logan S, Arnold J, Knesel B, Smith GD. Cancer; 2006 Dec 25; 108(6):451-61. PubMed ID: 17078096 [Abstract] [Full Text] [Related]
51. Clinical significance of human papillomavirus genotype by linear array assay in Japanese women with uterine cervical lesions and type 16 physical status by in situ hybridization. Futai M, Watanabe J, Jobo T, Tsunoda S, Nishimura Y, Watanabe K, Okayasu I, Unno N. Int J Gynecol Cancer; 2009 Nov 25; 19(8):1396-401. PubMed ID: 20009896 [Abstract] [Full Text] [Related]
53. Potential impact of combined high- and low-risk human papillomavirus infection on the progression of cervical intraepithelial neoplasia 2. Okadome M, Saito T, Tanaka H, Nogawa T, Furuta R, Watanabe K, Kita T, Yamamoto K, Mikami M, Takizawa K, Japanese Gynecologic Oncology Group (JGOG). J Obstet Gynaecol Res; 2014 Feb 25; 40(2):561-9. PubMed ID: 24147758 [Abstract] [Full Text] [Related]
58. Influence of IL-6, IL-8, and TGF-β1 gene polymorphisms on the risk of human papillomavirus-infection in women from Pernambuco, Brazil. Lima SF, Tavares MM, Macedo JL, Oliveira RS, Heráclio SA, Maia MM, Souza PR, Moura R, Crovella S. Mem Inst Oswaldo Cruz; 2016 Nov 25; 111(11):663-669. PubMed ID: 27783717 [Abstract] [Full Text] [Related]